Tanaka, Y.Immunol Rev, , 148, 171-99, PMID: 8825287
Anel, A.European journal of immunology, , 25, 3381-7, PMID: 8566027
Tonnelle, C.Ann N Y Acad Sci, , 764, 231-41, PMID: 7486530
Malissen, B.Ann N Y Acad Sci, , 766, 173-81, PMID: 7486653
Golstein, P.Immunol Rev, , 146, 45-56, PMID: 7493759
Renard, V.Proc Natl Acad Sci U S A, , 92, 7545-9, PMID: 7638228
deLapeyriere, O.Differentiation, , 58, 351-9, PMID: 7622010
Golstein, P.Cell, , 81, 185-6, PMID: 7537635
Vignaux, F.J Exp Med, , 181, 781-6, PMID: 7530763
Two signaling pathways can lead to Fas ligand expression in CD8
Anel,A.European Journal of Immunology, , 25, 3381-3387
Fas-based T cell-mediated cytotoxicity
Golstein,P.Pathways for cytolysis, Current Topics in Microbiology and Immunology, , 25-37
Deux mécanismes moléculaires pour la cytotoxicité T : perforine / granzymes et Fas
Golstein,P.Medecine / Sciences, , 11, 99-104
Fas bridging cell death and cytotoxicity. The reaper connection
Golstein,P.Immunological Reviews, , 146, 45-56
Homology between Reaper and the cell death domains of Fas and TNFR1. Letter to the Editor
Golstein,P.Cell, , 81, 185-186
Molecular mechanisms of T lymphocyte cytotoxicity, with emphasis on the Fas pathway
Golstein,P.Apoptosis and the Immune Response, , 143-168
The Fas death factor
Nagata,S.Science, , 267, 1449-1456
The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity
Nakajima,H.Journal of Experimental Medicine, , 181, 1905-1909